Literature DB >> 7577953

pH dependence of ligand binding to D2 dopamine receptors.

U M D'Souza1, P G Strange.   

Abstract

The binding of a range of ligands to D2 dopamine receptors in bovine caudate nucleus and recombinant CHO cells expressing the receptor has been determined at different pH values between 4.5 and 8.5. The maximum number of D2 dopamine receptor binding sites in each tissue was not affected by the change in pH, but the affinity of ligands for binding to the receptors was decreased as the pH was decreased. For classical dopamine antagonists, e.g. spiperone and haloperidol, the data on pH dependence of the dissociation constant for receptor binding indicated that the protonation of a single ionizing group on the receptor (pKa approximately 6) influenced the binding process. For antagonists of the substituted benzamide class, the data indicated that the protonation of two ionizing groups (pKa between 6 and 7) influenced the ligand binding process. These ionizing residues may correspond to Asp 114 for the classical antagonists and Asp 114 and Asp 80 for the substituted benzamide antagonists. Further evidence for the participation of carboxyl residues in the ligand binding process was obtained from the inhibition by N,N'-dicyclohexylcarbodiimide of the binding of [3H]spiperone and [3H]YM 09151-2 to D2 receptors in the recombinant CHO cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577953     DOI: 10.1021/bi00041a044

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  Ocean Acidification Amplifies the Olfactory Response to 2-Phenylethylamine: Altered Cue Reception as a Mechanistic Pathway?

Authors:  Paula Schirrmacher; Christina C Roggatz; David M Benoit; Jörg D Hardege
Journal:  J Chem Ecol       Date:  2021-05-20       Impact factor: 2.793

2.  The influence of different cellular environments on PET radioligand binding: an application to D2/3-dopamine receptor imaging.

Authors:  Darren R Quelch; Sarah L Withey; David J Nutt; Robin J Tyacke; Christine A Parker
Journal:  Neuropharmacology       Date:  2014-06-06       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.